7 Aug 2026 (Navroze Bureau) : A new report has highlighted a significant increase in the supply of Buprenorphine tablets to Punjab’s jails, stating that 8.87 crore tablets have been issued so far this year.
The rise is reportedly linked to efforts aimed at managing opioid dependence and expanding de-addiction treatment among inmates.
Sharp Increase in Supply
According to the report, the number of Buprenorphine tablets supplied to prisons has risen substantially compared to previous years.
Officials say the medication is being provided as part of treatment programmes for inmates struggling with opioid addiction.
Role of Buprenorphine
Buprenorphine is commonly used in opioid substitution therapy (OST) to help reduce withdrawal symptoms and support recovery from opioid dependence under medical supervision.
Health experts consider it an important component of de-addiction programmes when administered in a regulated setting.
Focus on Prison Rehabilitation
The increased supply reflects ongoing efforts to strengthen healthcare and rehabilitation services within Punjab’s prison system.
Authorities aim to reduce substance dependence among inmates and improve their chances of successful rehabilitation after release.
Monitoring and Oversight
Officials said the distribution and use of Buprenorphine in prisons are subject to medical supervision and regulatory oversight to ensure appropriate use and prevent misuse.